FDA-Authorized At-Home Syphilis Test Available Nationwide
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
NOWDiagnostics has launched the First To Know Syphilis Test, an FDA-authorized over-the-counter syphilis test in the U.S.
Virax Biolabs secured a distribution agreement to commercialize Mpox detection kits across Europe and for Gulf Cooperation Council nations.
There has been significant rise in sexually transmitted infections (STIs), underscoring the need for improved STI testing and diagnostics.
Emphasizing the healthcare disparities through increased testing for effective prevention of congenital syphilis needs addressing.
Read MoreNOWDiagnostics submitted a De Novo Classification Request to the U.S. FDA for the company’s First to Know at-home syphilis test.
Read MoreThe FDA is providing this information to educate health care providers and clinical laboratory staff and reduce the risk of false results.
Read MoreThe company began commercial shipments as part of the initial purchase order for 2.5 million tests, with further shipments scheduled.
Read MoreQuidelOrtho received 510(K) clearance from the FDA for its innovative Savanna PCR platform and Savanna HSV 1+2/VZV in vitro diagnostic test
Read MoreHIV can hide in the body for many years before symptoms appear. Meanwhile, it is quietly killing part of the immune system.Â
Read MoreThe FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
Read MoreAsh Wellness announced new community data on its StopHIVATL campaign to address the STI and HIV epidemic in Atlanta.
Read MoreThe World Health Organization (WHO) shared updated guidance on testing and diagnosing sexually transmitted infections (STI).
Read MoreSelf-collected tests performed similarly to provider-collected tests for detecting common sexually transmitted infections (STIs).
Read MorePreventx is opening a specialized lab for U.S. public health departments to help control the spread of STis in their communities.
Read MoreSimple HealthKit has launched an at-home test for five common STIs: chlamydia, gonorrhea, trichomoniasis, HIV, and syphilis.
Read MoreA quick diagnostic test developed by a Washington State University researcher may help curb the prevalent STI Trichomonas vaginalis.
Read MoreNew research found that STI and HIV testing declined at the onset of the COVID pandemic, while there was an increase in positive test rates.
Read MoreA quick, affordable diagnostic finger-prick test may help curb one of the most prevalent but least discussed sexually transmitted infections.
Read More